This site is new - feedback and suggestions welcome via GitHub issues.

#adherence — Thursday, September 17, 2026 (1 items)

hot top new auto
← prev day next day →
0 ℹ Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial. (linkinghub.elsevier.com) robot Bwakura-Dangarembizi M … Pett S The Lancet 2026-09-17 #hiv #clinical trial #adolescent #adherence